These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 7702633

  • 1. Characterization of an anthracycline-resistant human promyelocyte leukemia (HL-60) cell line with an elevated MDR-1 gene expression.
    Jönsson K, Dahlberg N, Tidefelt U, Paul C, Andersson G.
    Biochem Pharmacol; 1995 Mar 15; 49(6):755-62. PubMed ID: 7702633
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. P-glycoprotein and alterations in the glutathione/glutathione-peroxidase cycle underlie doxorubicin resistance in HL-60-R, a subclone of the HL-60 human leukemia cell line.
    Raghu G, Pierre-Jerome M, Dordal MS, Simonian P, Bauer KD, Winter JN.
    Int J Cancer; 1993 Mar 12; 53(5):804-11. PubMed ID: 8095491
    [Abstract] [Full Text] [Related]

  • 5. Functional expression of yeast artificial chromosome-human multidrug resistance genes in mouse cells.
    Kusaba H, Kohno K, Asakuno K, Kuwano M, Okumura K, Green ED, Schlessinger D, Wada M.
    Genome Res; 1995 Oct 12; 5(3):245-58. PubMed ID: 8593612
    [Abstract] [Full Text] [Related]

  • 6. Up-regulation of P-glycoprotein expression in rat liver cells by acute doxorubicin treatment.
    Fardel O, Lecureur V, Daval S, Corlu A, Guillouzo A.
    Eur J Biochem; 1997 May 15; 246(1):186-92. PubMed ID: 9210482
    [Abstract] [Full Text] [Related]

  • 7. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
    Takeshita H, Kusuzaki K, Ashihara T, Gebhardt MC, Mankin HJ, Hirasawa Y.
    J Bone Joint Surg Am; 2000 Jul 15; 82-A(7):963-9. PubMed ID: 10901311
    [Abstract] [Full Text] [Related]

  • 8. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL, Overman MJ, Petrofski JA, Campbell PA, de Marzo AM, Nelson WG.
    Int J Oncol; 2000 Dec 15; 17(6):1077-86. PubMed ID: 11078791
    [Abstract] [Full Text] [Related]

  • 9. MDR-1 gene expression is a minor factor in determining the multidrug resistance phenotype of MCF7/ADR and KB-V1 cells.
    Kim HM, Oh GT, Hong DH, Kim MS, Kang JS, Park SM, Han SB.
    FEBS Lett; 1997 Jul 21; 412(1):201-6. PubMed ID: 9257720
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Restoration of retinoid sensitivity by MDR1 ribozymes in retinoic acid-resistant myeloid leukemic cells.
    Matsushita H, Kizaki M, Kobayashi H, Ueno H, Muto A, Takayama N, Awaya N, Kinjo K, Hattori Y, Ikeda Y.
    Blood; 1998 Apr 01; 91(7):2452-8. PubMed ID: 9516145
    [Abstract] [Full Text] [Related]

  • 12. Different vimentin expression in two clones derived from a human colocarcinoma cell line (LoVo) showing different sensitivity to doxorubicin.
    Conforti G, Codegoni AM, Scanziani E, Dolfini E, Dasdia T, Calza M, Caniatti M, Broggini M.
    Br J Cancer; 1995 Mar 01; 71(3):505-11. PubMed ID: 7880731
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients.
    Ross DD, Doyle LA, Schiffer CA, Lee EJ, Grant CE, Cole SP, Deeley RG, Yang W, Tong Y.
    Leukemia; 1996 Jan 01; 10(1):48-55. PubMed ID: 8558937
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of the multidrug resistance genes mdr1, mdr3, and mrp in L1210 leukemia cells resistant to inhibitors of ribonucleotide reductase.
    Rappa G, Lorico A, Liu MC, Kruh GD, Cory AH, Cory JG, Sartorelli AC.
    Biochem Pharmacol; 1997 Sep 15; 54(6):649-55. PubMed ID: 9310341
    [Abstract] [Full Text] [Related]

  • 18. Analysis of a novel cDNA encoding a C219-reactive peptide isolated from methotrexate-selected multidrug-resistant human leukemic cells.
    Norris MD, Gilbert J, Madafiglio J, Haber M.
    Gene; 1995 Apr 24; 156(2):313-4. PubMed ID: 7758977
    [Abstract] [Full Text] [Related]

  • 19. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J, Fang X, Hao J, Sha X.
    Biomaterials; 2015 Mar 24; 45():99-114. PubMed ID: 25662500
    [Abstract] [Full Text] [Related]

  • 20. Modulation of multidrug resistance gene (mdr-1) with antisense oligodeoxynucleotides.
    Liu C, Qureshi IA, Ding X, Shan Y, Huang Y, Xie Y, Ji M.
    Clin Sci (Lond); 1996 Jul 24; 91(1):93-8. PubMed ID: 8774266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.